Nasdaq: ALNY
Alnylam Pharmaceuticals insiders
The officers, directors and 10% owners of Alnylam Pharmaceuticals, Inc. who hold the most stock, valued at the live ALNY price.
$147.82
ALNY today −$1.6M (−1.06%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 10
- Their ALNY stock
- $109M
- Market value
- $19.80B
- Held by ranked insiders
- 0.55%
Insiders by value of ALNY holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Phillip A. Sharp | Director | 266,899 | $39.5M | 0.20% | 2946th |
| 2 | John Maraganore | Chief Executive Officer | 230,796 | $34.1M | 0.17% | 1983rd |
| 3 | Yvonne Greenstreet | Chief Executive Officer | 85,209 | $12.6M | <0.1% | 7178th |
| 4 | Jeffrey Poulton V. | EVP, Chief Financial Officer | 61,862 | $9.1M | <0.1% | 9374th |
| 5 | Tolga Tanguler | EVP, Chief Commercial Officer | 34,297 | $5.1M | <0.1% | 14320th |
| 6 | David E. I. Pyott | Director | 33,262 | $4.9M | <0.1% | 9651st |
| 7 | Akshay Vaishnaw | President | 23,289 | $3.4M | <0.1% | 3321st |
| 8 | Steven M. Paul | Director | 1,000 | $148K | <0.1% | 3876th |
| 9 | Carolyn R. Bertozzi | Director | 775 | $115K | <0.1% | 3553rd |
| 10 | Stuart A. Arbuckle | Director | 671 | $99K | <0.1% | 3307th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Alnylam Pharmaceuticals; see each profile for the filing.